ArticleCancer research and treatment2026

A Novel CD58 Mutation-Related Signature Predicts Prognosis Risk in Diffuse Large B-Cell Lymphoma Patients.

Hui-Li Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.